T4 coliphage cocktail (Nestlé)
AXP000245.1 · Phage therapy
- Platform
- phage cocktail (non-engineered)
- Originator
- Nestlé Research Centre
- Sponsor
- Société des Produits Nestlé
Names
| Name | Type | Source |
|---|---|---|
| T4 coliphage cocktail (Nestlé) | preferred name | curator |
| T4 phage cocktail | synonym | ctgov |
Virus
- Role
- Phage
- Family
- Straboviridae
- Virus
- Escherichia coli T4-like bacteriophage (cocktail)
- Replication
- replicating
- Route
- oral
- Source
- evidence
Approvals
No regulatory approval recorded.
Clinical trials (1)
| Trial | Title | Status | Phase | Start | Primary completion | Enrolment | Conditions |
|---|---|---|---|---|---|---|---|
| NCT00937274 | Antibacterial Treatment Against Diarrhea in Oral Rehydration Solution | Terminated | 2009-08 | 2013-01 | 120 | Diarrhea |
Recent changes
No changes recorded in its trials yet.
Clinical papers
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 26981577 | cited by trial NCT00937274 |
Notes
Orally given T4-like coliphage preparation tested in Bangladeshi children with E. coli diarrhoea (NCT00937274, terminated; published 2016). The trial compared a Nestlé-made cocktail with a commercial Russian T4 preparation; this program is the Nestlé cocktail.
How to cite
T4 coliphage cocktail (Nestlé) (AXP000245.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000245.html
Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.